This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

18 Apr 2012

Takeda Announces URL Pharma Acquisition

Takeda is enhancing its gout treatment portfolio with the acquisition of URL Pharma.

Takeda Pharmaceutical Company has announced that its wholly owned subsidiary Takeda America Holdings is to acquire URL Pharma.


The privately held pharmaceutical company will be acquired for an upfront payment of $800 million, along with performance-based payments in the future.


It will subsequently be managed by Takeda Pharmaceuticals USA.


Douglas Cole, president of Takeda Pharmaceuticals USA, revealed that the deal will expand the company's gout treatment portfolio, as URL Pharma's lead product is Colcrys (colchicine), which is used to treat and prevent gout flares.


He said: "Gout affects mor

Related News